[Skip to Content Landing] Sign in to your personal account Institutional sign in: OpenAthens | Shibboleth Purchase access Buy this article and get unlimited access and a printable PDF ($30.00) - Sign in or create a free account Rent this article for read-only access ($8.99) Sign in to download free article PDFs Sign in to your personal account Institutional sign in: OpenAthens | Shibboleth Get free access to newly published articles Create a personal account or sign in to: Register for email...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mo Yin
Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by high morbidity and mortality and remains challenging in treatment. Dendritic cells (DCs) have been shown to participate in the initiation and perpetuation of lupus pathogenesis. DCs that can induce tolerogenicity appear as potential cell-based therapy in this condition. In this study, we examined the in vitro tolerogenic properties of bone-marrow derived DCs (BMDCs) in the murine lupus setting.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mo
Contact Mo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack